Sensus Healthcare, Inc. (SRTS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 5M 10M 15M Q3 '21: 5.5M Q4 '21: 13M Q1 '22: 10.3M Q2 '22: 12.1M Q3 '22: 9M Q4 '22: 13.1M Q1 '23: 3.4M Q2 '23: 4.5M Q3 '23: 3.9M Q4 '23: 12.6M Q1 '24: 10.7M Q2 '24: 9.2M Q3 '24: 8.8M Q4 '24: 13.1M Q1 '25: 8.3M Q2 '25: 7.3M Q3 '25: 6.9M Q4 '25: 4.9M Q1 '26: 3.4M Q2 '26: 2.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 3.5M 7M 10.5M Q3 '21: 3.2M Q4 '21: 8.9M Q1 '22: 7.1M Q2 '22: 8.3M Q3 '22: 5.9M Q4 '22: 8.3M Q1 '23: 1.6M Q2 '23: 2.6M Q3 '23: 2M Q4 '23: 7.8M Q1 '24: 6.7M Q2 '24: 5.4M Q3 '24: 5.2M Q4 '24: 7.1M Q1 '25: 4.4M Q2 '25: 2.9M Q3 '25: 2.7M Q4 '25: 1.9M Q1 '26: 991K Q2 '26: 769K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-6M -4M -2M 0 2M 4M 6M Q3 '21: 195K Q4 '21: 5.3M Q1 '22: 3.9M Q2 '22: 4.6M Q3 '22: 2.2M Q4 '22: 4.2M Q1 '23: -2.9M Q2 '23: -1.1M Q3 '23: -1.9M Q4 '23: 5.6M Q1 '24: 2.9M Q2 '24: 2M Q3 '24: 1.5M Q4 '24: 1.7M Q1 '25: -2.6M Q2 '25: -1.9M Q3 '25: -2.6M Q4 '25: -3.1M Q1 '26: -4.4M Q2 '26: -3.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-12M -6M 0 6M 12M 18M Q3 '21: 195K Q4 '21: 5.3M Q1 '22: 16.1M Q2 '22: 3.5M Q3 '22: 1.8M Q4 '22: 2.8M Q1 '23: -1.9M Q2 '23: -380K Q3 '23: -1.5M Q4 '23: 4.2M Q1 '24: 2.3M Q2 '24: 1.6M Q3 '24: 1.2M Q4 '24: 1.5M Q1 '25: -2.6M Q2 '25: -1M Q3 '25: -943K Q4 '25: -3.2M Q1 '26: -2.6M Q2 '26: -8.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 2.5M 5M 7.5M Q3 '21: 2.3M Q4 '21: 4.2M Q1 '22: 3.2M Q2 '22: 3.8M Q3 '22: 3.1M Q4 '22: 4.8M Q1 '23: 1.8M Q2 '23: 1.9M Q3 '23: 1.9M Q4 '23: 4.7M Q1 '24: 4M Q2 '24: 3.8M Q3 '24: 3.6M Q4 '24: 6M Q1 '25: 4M Q2 '25: 4.4M Q3 '25: 4.2M Q4 '25: 3M Q1 '26: 2.4M Q2 '26: 1.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-9M -6M -3M 0 3M 6M 9M Q2 '21: 1.4M Q3 '21: 1.3M Q4 '21: -1.8M Q1 '22: 3.1M Q2 '22: 1.9M Q3 '22: 3.7M Q1 '23: -6M Q2 '23: 742K Q3 '23: 442K Q4 '23: 2.7M Q1 '24: -8.2M Q2 '24: 4.2M Q3 '24: 4M Q4 '24: -827K Q1 '25: -2.7M Q2 '25: 3.1M Q3 '25: 2.3M Q4 '25: -2.2M Q1 '26: -3.8M Q2 '26: -3.1M Q3 '21 Q2 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-9M -6M -3M 0 3M 6M 9M Q1 '21: -1.2M Q2 '21: 1.3M Q3 '21: 1.2M Q4 '21: -1.8M Q1 '22: 3M Q2 '22: 1.9M Q3 '22: 3.7M Q1 '23: -6.2M Q2 '23: 713K Q3 '23: 431K Q4 '23: 2.7M Q1 '24: -8.4M Q2 '24: 4.2M Q3 '24: 3.6M Q1 '25: -2.7M Q2 '25: 3.1M Q3 '25: 2.3M Q4 '25: -2.4M Q1 '26: -3.8M Q2 '26: -3.1M Q2 '21 Q1 '22 Q1 '23 Q4 '23 Q3 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 6M 12M 18M Q2 '19: 16.4M Q2 '20: 16.4M Q3 '20: 16.5M Q1 '21: 16.5M Q2 '21: 16.5M Q3 '21: 16.5M Q1 '22: 16.6M Q2 '22: 16.6M Q3 '22: 16.6M Q1 '23: 16.2M Q2 '23: 16.2M Q3 '23: 16.3M Q1 '24: 16.3M Q2 '24: 16.3M Q3 '24: 16.3M Q1 '25: 16.3M Q2 '25: 16.3M Q3 '25: 16.3M Q1 '26: 16.5M Q2 '26: 16.5M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.20 -0.60 0.00 0.60 1.20 1.80 Q3 '21: -0.02 Q4 '21: 0.24 Q1 '22: 1.28 Q2 '22: 1.51 Q3 '22: 1.61 Q4 '22: 1.47 Q1 '23: 0.38 Q2 '23: 0.15 Q3 '23: -0.05 Q4 '23: 0.03 Q1 '24: 0.29 Q2 '24: 0.41 Q3 '24: 0.57 Q4 '24: 0.41 Q1 '25: 0.11 Q2 '25: -0.05 Q3 '25: -0.18 Q4 '25: -0.47 Q1 '26: -0.47 Q2 '26: -0.94 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.